Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1990-12-06
1993-10-12
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514554, 514557, A61K 3122, A61K 31205, A61K 3119
Patent
active
052526038
ABSTRACT:
Succinylacetone derived or related medicaments and methods of synthesis of the same are shown wherein the medicaments consists of succinylacetonyl-proline-PEG, succinylacetonyl-NH-PEG, or compounds that have the formula: ##STR1## wherein n=1-6
REFERENCES:
patent: 4670467 (1987-06-01), Hess et al.
patent: 4760090 (1988-07-01), Nissen
patent: 4764531 (1988-08-01), Nissen
patent: 4835185 (1989-05-01), Nissen
Tschudy, D., et al., 1982, Chem. Abstracts, 96:210579d.
Weinback, E. C., et al., 1985, Chem. Abstracts, 103:35547f.
Beaumont, C., et al., 1986, Chem. Abstracts, 105:150346t.
Hoult, R. C., et al., 1986, Chem. Abstracts, 105:222421p.
Hamilton, J. W., et al., 1988, Chem. Abstracts, 106:167885y.
Skolik, S. A., et al., 1988, Chem. Abstracts, 109:183224n.
Aldwin Lois
Braude Irwin
Levenson Corey H.
Mark David F.
Moreland Margaret
Cetus Corporation
Fay Zohreh A.
Giotta Gregory J.
Halluin Albert P.
Waddell Frederick E.
LandOfFree
Immunosuppressive analogues and derivatives of succinylacetone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunosuppressive analogues and derivatives of succinylacetone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunosuppressive analogues and derivatives of succinylacetone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1904842